4
Changes in Ownership
Caribou Biosciences, Inc. Filed Acc 0001209191-22-047748
Chief Scientific Officer sold 43,248 shares at $11.22 ($485,221)
- Chief Scientific Officer acquired 43,248 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kanner Steven · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-25 | Exercise or conversion : show line 1 in the form | +43,248 | $2.69 | $116,337 | 345,307 | D |
| 2022-08-25 | Sale : show line 2 in the form | −43,248 | $11.22 | $485,221 | 302,059 | D |
| Open-market sales · 43,248 sh · avg $11.22 · $485,221 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-25 | Exercise or conversion : show line 3 in the form Option to purchase Common Stock | −43,248 | 73,601 | D |
Loading xslF345X03/doc4.xml…